Contaminants in API and Drugs, an emerging concern into Pharma sector

Synopsis

Over the last few years, the problem related to the contamination of APIs and therefore finished drug products, has becomeincreasigly topical and has forced the pharmaceutical companies to overhaul their manifacturing processes.
The nature of contaminants to be monitored depends on the synthesis route of API itslef and the monitoring of contaminantsin APIs and Durg product cannot be separated from the analytical control.